Rhythm Pharmaceuticals

North America Legal Chronicle. April 8, 2024

Rhythm Pharmaceuticals’ $150 Million Financing

By Leila Ahmed

Latham & Watkins is advising Rhythm Pharmaceuticals on the transaction, and Ropes & Gray is advising Perceptive Advisors LLC. Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (Rhythm), a commercial-stage...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

North America Legal Chronicle. June 23, 2022

Rhythm Pharmaceuticals’ $100 Million Revenue Interest Financing Agreement With HealthCare Royalty Partners

By Laura Testa

Latham & Watkins represented Rhythm Pharmaceuticals, Inc. in the transaction, while Morgan, Lewis & Bockius acted as legal advisor to HealthCare Royalty. Rhythm Pharmaceuticals, Inc. (Nasdaq:...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Amcor’s $37 Billion Merger with Berry Global

SBL Holdings’ $650 Million Senior Notes Offering

Huntington’s $1.75 Billion Notes Offering

YPF Luz’s US$420 Million Notes Issuance

360 Energy Solar’s US$22 Million Green Notes Issuance

Eneva’s Acquisition of Tevisa Termelétrica Viana, Povoação Energia, Linhares Brasil Energia Participações, and 50% of Geradora de Energia do Maranhão

Helarb Group’s Acquisition of Pantucci Thermolaquage SA

TM TRADE POL’s Shares Sale

Charme Capital Partners’ Acquisition Of Centogene GmbH

Tamweely’s EGP 5 Billion Securitization Program

TE H2, CIP, and A.P. Moller Capital’s Developmente Of Large-Scale Green Hydrogen Project In Morocco

Camusat Holding’s €81 Million Mezzanine Investment Round

Commercial Bank of Dubai’s US$500 Million Bond Issuance

Medianova’s Investment Round

Lulu Retail Holdings Plc’s $1.72 Billion IPO On ADX

AGC Automotive (Thailand) Co., Ltd. v. Renewable Energy for Thai People Co., Ltd.

Profectus Capital’s Non-Convertible Debentures Issuance

NBL and LK Group’s Investment in WNBL

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

Rhythm Pharmaceuticals’ $150 Million Financing

Standard 1 Year Membership Required

Rhythm Pharmaceuticals’ $100 Million Revenue Interest Financing Agreement With HealthCare Royalty Partners

Standard 1 Year Membership Required